Note 17 - (Loss) Earnings Per Share - Summary of Antidilutive Securities (Details) - shares	3 Months Ended	9 Months Ended
Aug. 31, 2026	Aug. 31, 2025	Aug. 31, 2026	Aug. 31, 2025
Antidilutive securities (in shares)	1,551,517	20,919	1,551,517	41,944
Share-Based Payment Arrangement, Option [Member]
Antidilutive securities (in shares)	1,062,835	0	1,062,835	0
Restricted Stock Units (RSUs) [Member]
Antidilutive securities (in shares)	488,682	20,919	488,682	41,944

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration